The United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan; Department of Molecular Pathobiochemistry, Graduate School of Medicine, Gifu University, Gifu, Japan.
Biophys J. 2018 Feb 27;114(4):885-892. doi: 10.1016/j.bpj.2017.12.031.
Prion diseases are associated with the structural conversion of prion protein (PrP) to a β-sheet-rich aggregate, PrP. Previous studies have indicated that a reduction of the disulfide bond linking C179 and C214 of PrP yields an amyloidlike β-rich aggregate in vitro. To gain mechanistic insights into the reduction-induced aggregation, here I characterized how disulfide bond reduction modulates the protein folding/misfolding landscape of PrP, by examining 1) the equilibrium stabilities of the native (N) and aggregated states relative to the unfolded (U) state, 2) the transition barrier separating the U and aggregated states, and 3) the final structure of amyloidlike misfolded aggregates. Kinetic and thermodynamic experiments revealed that disulfide bond reduction decreases the equilibrium stabilities of both the N and aggregated states by ∼3 kcal/mol, without changing either the amyloidlike aggregate structure, at least at the secondary structural level, or the transition barrier of aggregation. Therefore, disulfide bond reduction modulates the protein folding/misfolding landscape by entropically stabilizing disordered states, including the U and transition state of aggregation. This also indicates that the equilibrium stability of the N state, but not the transition barrier of aggregation, is the dominant factor determining the reduction-induced aggregation of PrP.
朊病毒疾病与朊病毒蛋白 (PrP) 的结构转换为富含β-折叠的聚集体,PrP 有关。先前的研究表明,降低 PrP 中 C179 和 C214 之间的二硫键会在体外产生类似淀粉样的富含β的聚集体。为了深入了解还原诱导聚集的机制,我通过检查 1)天然(N)和聚集态相对于未折叠(U)态的平衡稳定性,2)U 和聚集态之间的转变障碍,以及 3)淀粉样错误折叠聚集体的最终结构,来研究二硫键还原如何调节 PrP 的蛋白折叠/错误折叠景观。动力学和热力学实验表明,二硫键还原降低了 N 态和聚集态的平衡稳定性,约为 3 kcal/mol,而不会改变淀粉样聚集结构,至少在二级结构水平上,也不会改变聚集的转变障碍。因此,二硫键还原通过熵稳定无序状态来调节蛋白折叠/错误折叠景观,包括 U 和聚集的转变状态。这也表明,N 态的平衡稳定性,而不是聚集的转变障碍,是决定 PrP 还原诱导聚集的主要因素。